DCF — SANTA ROSA HEALTHCARE
Enterprise Value: $-760.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-760.5M
Enterprise Value
$-242.8M
PV of Cash Flows
$-517.8M
PV of Terminal Value
$-833.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $539.8M | $-46.2M | -9.0% | $-69.1M | $-62.8M |
| Year 2 | $556.0M | $-42.0M | -8.0% | $-65.6M | $-54.2M |
| Year 3 | $572.7M | $-37.6M | -7.0% | $-61.8M | $-46.4M |
| Year 4 | $589.8M | $-35.7M | -6.0% | $-60.7M | $-41.5M |
| Year 5 | $607.5M | $-35.3M | -6.0% | $-61.0M | $-37.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-760.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$524.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.09060351290377325
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5